Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07817706Recruiting
Open-label, single-arm trial of Bronchitol, sponsored by Mayo Clinic. Primary endpoint: Peak Gastrointestinal Symptom Severity During Small Bowel Transit at 180 months. Started Sep 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07817706.